China does poineering work as professional as investment portal
The reporter learns, division hope medicine hands in those who finished 35 million dollar to increase investment in Xia Qiuzhi, get by tall Ling capital cast, investment just includes a ceremony to come He Dinghui invests Asian fund, up to now, division the investment that hopes altogether already acquired 55 million dollar.
Origin | Invest bound PEdaily
Tumor immunity treats the 3rd revolution that treating in open cancer. On November 20, division the first when look at medicine clinical product submits IND application formally, the mark is worn division the beginning that looks at a when lead tumor immunity cure important milestone. Future, division hope medicine predicts to will keep annual product of 1-2 money innovation submits IND application, continual the product that rolls out high quality enters clinical phase. In the meantime, division hope medical CEO Ji Xiaohui also approves dew to media first: Division hope medicine obtains a ceremony to come capital of Asian fund, tall Ling, vessel sunshine investment add up to the investment of 55 million dollar.
"Times of the PD1-PDL1 after our scan widely, the immunity that is dedicated to finding the 2nd generation, the 3rd generation then treats a product. " division when hoping medical CEO Ji Xiaohui is accepting investment group special report, express. PD1-PDL1 immunity therapeutics is current equipment suffers the new generation that fix eyes upon to refuse tumor treatment, but inferior patient respondent rate makes means of this one cure still is put in the space that continues to break through.
Make innovation from fountainhead, lead global tumour immunity 2 revolution
Cancer is the most dangerous devil in human life. Calculate data according to global cancer comes on and dying, predicted global cancer comes on 2020 sixteen million five hundred and five thousand person, dead number will amount to 10.36 million person, cancer disease sent China 2030 5 million person, dead number will amount to 3.86 million person.
Accompanying tumor incidence of a disease and mortality to lift, more and more people are devoted into drive the journey that fights tumor to treat a technology to innovate. In generation staff member of another acting medical treatment is mixed under the effort that studies an expert, tumor treated therapeutics of technical afterwards operation to experience revolution 3 times, it is to change for the first time cure and the medicaments that put cure, it is target the 2nd to medicaments, it is immune therapeutics the 3rd.
relatively at the operation, change cure to put cure, target to medication wait for other treatment means, immune therapeutics is very remarkable to getting used to disease curative effect, poisonous side effect is little, counter tumor recrudesce move, apparent to effect of terminal cancer patient. Be in China nowadays, dedicated the medical look forward to that treats at tumor immunity does not issue hundreds. "Company of state-owned very much medicine is in in do tumor immunity, but we are a few amount to is very few companies that become innovation in fountainhead truly. " Ji Xiaohui says.
Doing poineering work, BD, feel with the domain such as medical research and development climb boil dozen old, ji Xiaohui and collective author hold presiding and scientific Guan Luhong concurrently to sheath or bow case, big Ga of bound of associated world antibody Dr. Shen Wenyan established 2017 division look at medicine. They are right division the fixed position that looks at medicine is " set out from immunology angle, the difficult problem that captures tumor had be notted solve, immunity of tumour of the generation below the leader treats 2 revolution " .
Division hope medicine is virgin group and group photo of scientific advisory body
So called " 2 revolution " , it is to point to plunge into in large quantities of companies when pushing field of immunity of acquired character of research and development, division key systematization position had before hoping medicine has been carried around natural immunity, attack continuously " Cold Tumor " (cold tumour) , the target has tumor immunity treatment not respondent or recrudescent patient.
Low respondent it is existence of domain of tumor immunity cure one catastrophe problem. In the use process of PD1-PDL1 medicaments, only 20% arrive the respondent rate of 40% , when treating lymphatic tumor may a few taller, but more it is to be not had at all respondent, respondent perhaps aftereffect fruit is not strong. How does the rest patient do? "The space is very large, immune cure is only just open a new page. Division those who hope to want to do is effort solve without respondent tumor difficult problem. " Ji Xiaohui expresses.
Establish the whole world the most powerful head, have science, have carry out, have sth used to one's own advantage
To come true this wishs scene, division look at medical assemble the most powerful head is the whole world the strategy of research and development of the company escorts the Emperor convoy. Division in the scientific committee member that visit, have the Arlene Sharp of haing Buddha university, vijay Kuchroo, the Phillip Greenberg of Washington university, the professors such as the Thomas Gajewski of Chicago university. These world-class scientists ever also established the tumor immunity company of many successes, include Juno Therapeutics, CoStim Pharmaceuticals, Jounce Therapeutics to wait.
"Why tumor immunity can help a few patients only now. The most primary reason is us those who lack pair of biology is more deep-seated second understanding, nod understanding to the character of cell of each kinds of tumour, target degree is insufficient. Want to find the target site that can use drug and new-style remedy, need authority make concerted effort. We have good fortune can have desire and capable global talent gathers, for common cause tries hard. " Ji Xiaohui says.
Ji Xiaohui obtains clinical M.d. degree in Chinese medical university, university of heart of Er thanking phenanthrene obtains molecular biology and biology engineering doctor's degree, obtain MBA degree at business school of Chicago university Booth. Vice-president of whole world of family name of Ceng Ren collect holds commerce concurrently to develop chief, the commercial development of the market in leading collect family name to reach development in the Asia, product is introduced reach annex to buy, ever also held the post of commerce of area of East Asia of treasure clean company to develop chief.
Be worth what carry is, ji Xiaohui holds the dual role of the person that do poineering work and investor concurrently personally. 2017, ji Xiaohui takes up the post of a ceremony to come partner of Asian fund venture, the plan is established and run company of new-style biology pharmacy. The ceremony comes the venture that Asian fund makes new drug to investment and accrual accuse to having original vision and hold to.
Division look at medical CEO Ji Xiaohui
Hold water division look at medicine is Ji Xiaohui to do poineering work again. Speak of what do poineering work again is different, ji Xiaohui laugh says: "Loosened this a lot of, state of mind is better, not so impatient, pay attention to the ability that develops each group member more. Pay attention to the ability that develops each group member more..
Lu Hongtao's personal details is very dazzling also. Lu Hongtao is in center of medicine of gram Li Fulan to obtain a doctor's degree, postdoctoral training division fastens director Richard A.Flavell from immunology of college of medicine of academician of American academy of sciences, Yale. He has rich experience of more than 20 years in medicaments development domain, early or late in Ge Lan element history is overcome, again the company such as vessel medicine holds the position of tall canal, medicaments of many innovation immunology is chaired to enter POC during holding a post clinical phase, own multinomial research patent.
Division hope collective author holds medicine concurrently presiding and scientific Guan Luhong sheaths or bow case
In division look establish a group in, still one is in the big Ga with celebrated reputation of domain of research and development of global antibody medicaments, dr. Shen Wenyan. Shen Wenyan is a few one or two with the not much amount to on the world the science and technology that many antibody medicine drives the market successfully from original research and development gets military thing. He holds the position of senior vice president of American NGM company at present, the part-time job is taken up the post of division look at directorate member and scientific committee chairman.
If a group wants to make innovation in biology medicine domain, ji Xiaohui thinks to need 3 kinds of talented people. "One kind is a scientist, do innovation to must want to have scientific talented person; One kind is the talented person that does a business, know how to discharge bureau embattle, carry out in order; One kind is the talented person that capital runs, biology medicine research and development needs many capital investment, a lot of companies are not to die on idea, shed shortage in cash to death however. " Ji Xiaohui says, "Should have science, have carry out, have sth used to one's own advantage, this at 3 o'clock must organic union rises. This at 3 o'clock must organic union rises..
Natural immunology speaks of talking after two years division look at medicine
One many year the family in time looked medicine to develop quickly in tumor immunity domain in the past. Current, the product cop of the company is enclothed in tumor immunity extensive, in the position of key of natural immunity domain that has latent capacity extremely, develop a school of one's own, compose built the 12 products cop with innovation extremely tall sex. Among them the remedy that the product of 30% orders to be based on complete innovation target, the 70% poor dissimilation that nod to be based on existing target design medicaments, laid solid foundation to did not combine cure.
Biology medicine arrives from research and development production, push often need an endless cycle to the market, this course is right of medical look forward to living is check of one final examination. Division hope medicine is current the first clinical product prepares to enter human body trial, next year of medicaments of the 2nd innovation is entered clinical. Clinical before product line a new force suddenly rises, the antibody drug manufacturer of Suzhou will be finished at be being built the end of next year, the company is in in full blast enlarge an army.
Division hope medicine has older ambition. As we have learned, division the target drop of the immune tumour that looks at dabble of project of medical research and development is more extensive, basically center in 4 respects: Distinctive target nods small environment of adaptability immunity, natural immunity, tumour and tumour.
"Division a territory that hopes at present the key pays close attention to is natural immunology. Opposite at acquired character immunity, natural immunity is the first defense line that airframe defies and cleared pathogen affects. " Ji Xiaohui expresses. "We own one party scope of operation in this domain, this also is the strong point of Dr. Lu Hongtao, he has a lot of original opinion to natural immunology. After two years, speak of natural immunology treating the development that go up in tumor, can speak of division look at medicine, speak of Lu Hongtao. Speak of Lu Hongtao..
To Ji Xiaohui character, division the job that hopes medicine is being done is not only do poineering work, also mean bigger liability, one devotes oneself to to settle cancer patient's pungent liability. He often says with the group members that do poineering work together, now division the thing that hopes medicine is being done is the most exciting, most challenge, most " amused " , also be the most significant.
Ji Xiaohui's current desire is hope family hopes the medicaments of medical research and development can let a patient get benefit as soon as possible, get the market approbate. Appear on the market to the company, after he thinks this just makes good drug the thing of success will come when conditions are ripe.
New financing of round of 35 million dollar,
Cast those representing capital civilized come, vessel sunshine with tall Ling capital
The reporter learns, the division that establishs more than one year hopes medicine hands in those who finished 35 million dollar to increase investment in Xia Qiuzhi, get by tall Ling capital cast, investment just includes a ceremony to come He Dinghui invests Asian fund, up to now, division the investment that hopes altogether already acquired 55 million dollar.
Be worth what carry is, division hope medicine is the ceremony comes to the company of tumor immunity treatment of hatch of Asian fund emphasis. From virgin group build, arrive A annulus is thrown solely and the collaboration of A+ annulus and tall Ling He Dinghui, the ceremony comes all the way in the company of goes. To this, the ceremony comes Lu Gongbo represents Asian fund partner: "We are very lucky can organic meeting and family hope the group cooperates hand in hand. Division those who look is virgin with administrative group assemble the optimal combination of science and commerce, have extremely strong internal research and development and international Licensing capacity. The group is in hold water more than one year IND is handed over inside time, have super- constant be born carries out ability. We thank tall Ling He Dinghui join in, hope powerful investor combines the long-term development that division of OK and collective support looks. Hope powerful investor combines the long-term development that division of OK and collective support looks..
The ceremony comes Asian fund (Lilly Asia Ventures) held water 2008, dedicated Yu Yazhou especially the equity of service of technology of Chinese biology medicine, biology, medical apparatus and instruments, medical treatment and domain of animal health care invests. Regard banner biology medicine risk as fund, the ceremony comes Asian fund is offerred to the enterprise of mark " wisdom capital " and globalization resource, quicken an enterprise to grow.
Serve as this round of financing get cast square, tall Ling capital is dedicated the company that invests at value of long-term structure sex, with its outstanding investment outstanding achievement invests a bound to enjoy high reputation in the whole world. Tall Ling regards key strategy as to invest way biology medicine and domain of medical treatment health all the time, and the biology medicine industry that early established major invests a group, of medicine of research and development of drug of technology of key attention biology, innovation, abroad innovation and medical treatment service introduce, mining is in the enterprise of medical treatment of global outstanding biology in growing quickly. And " do not seek short-term get one's own back " , " the friend that becomes time " equal in value value invests a concept, natural the trade law that agrees with medical innovation, make the advantage that tall Ling had a priori in the investment of this domain. Refer this round get cast division look, easy Nuo blueness represents partner of tall Ling capital: "Chinese technology innovation is being experienced from imitate achieve formerly, and even led crucial phase. Among them, medical industry is the town of military importance that sends innovation formerly, and with division the company of a batch of innovation that hopes to be a delegate, it is the core force that urges this one history to span, its are in of tumor immunity domain dedicated with innovation, the new era that immunity of hopeful open tumour treats, aid push whole industry to upgrade, bring more hopes for the patient. Bring more hopes for the patient..
Division hope medicine is a vessel sunshine innovation and the growing fund another major investment in life science domain. Vessel sunshine special value division the prominent author group that look. "Actually we are awaiting all the time division look get a soldier to just come out to do poineering work again. We are confident to the group, the investment of innovation drug type, virgin group is crucial, this group is to having rich successful experience undoubtedly, have the group of ability of company core competition, also be I see rare assiduous sureness, efficient inside the group of collect. " vessel sunshine innovation and Zhang Li of growing fund partner express. Nowadays, waited for years to receive a good result eventually.
Vessel sunshine invested virgin copartner Wang Lin to also disclose a vessel to investing a bound sunshine medical treatment group invests in biology technology domain from beginning to end importunate two principles: It is the trade that carries systematization research undertakes industry scanning and deepness are analysed, not be have one's view of the important overshadowed by the trivial, do not see a father-in-law, have the sufficient knowledge of catenary of pair of whole industry value already however, the fractionize domain that pays close attention to every again has careful research. Of the mark of such investment, it is the result that is based on the choice after understanding whole market, is not to invest and invest. 2 it is to devote oneself to for a long time to mix scientist, entrepreneur, father becomes the good friend that deserves credit, build with all possible means the ecology group of win-win, satisfy demand of the business that be cast. It is reported, vessel sunshine pharmacy of benefit of industry of drug of the greenery pharmacy of the investment before this, Kang Hong, general, sea organisms, big ginseng forest wait for enterprise of nearly 10 medical treatment to finish IPO successfully already, and a year in the past many, vessel sunshine innovation and growing fund in succession in succession layout with platinic medicine, forerunner drug industry, weather situation biology, stride new student content, the company of technology of forward position biology such as friend of Jiangsu Ai Erkang, friendly Zhi.
